No Magic in Anti-Obesity Pills and Profits By: CNBC.com News July 16, 2012 at 18:17 PM EDT Jim Cramer's researcher, Nicole Urken, reiterates the importance of assessing risk when speculating. Read More >> Related Stocks: Alexion Pharmaceuticals GNC Holdings Inc Gsk Plc ADR Hain Celestial Group Johnson & Johnson Mellanox Technologies Regeneron Pharmaceuticals Vivus Inc Whole Foods Market Willis Towers Watson Public Ltd